Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS : revenue, balance sheet and financial ratios

SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT OMER (62500), this company of category PME shows in 2022 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS (SIREN 829517671)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C 1 281 478 € N/C N/C N/C N/C N/C
Net income 71 456 € 110 811 € 188 794 € 196 809 € 115 137 € 91 023 € 176 365 € 7 044 €
EBITDA N/C N/C 256 169 € N/C N/C N/C N/C N/C
Net margin N/C N/C 14.7% N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS generates positive net income of 71 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 7 k€ -> 71 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

71 456 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 46%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

46.424%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

63.835%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

52.3%

Solvency indicators evolution
SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS

Sector positioning

Debt ratio
46.42 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good

In 2024, the debt ratio of SELARL DE PHARMACIENS D'O... (46.42) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
63.84% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +6 pts over 3 years

In 2024, the financial autonomy of SELARL DE PHARMACIENS D'O... (63.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
3.28 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good

In 2022, the repayment capacity of SELARL DE PHARMACIENS D'O... (3.28) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 523.71. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

523.714

Liquidity indicators evolution
SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS

Sector positioning

Liquidity ratio
523.71 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of SELARL DE PHARMACIENS D'O... (523.71) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
1.49x 2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average

In 2022, the interest coverage of SELARL DE PHARMACIENS D'O... (1.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS

Positioning of SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS is estimated at 997 578 € (range 694 697€ - 1 492 434€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
694k€ 997k€ 1492k€
997 578 € Range: 694 697€ - 1 492 434€
NAF 5 année 2024

Valuation method used

Net Income Multiple
71 456 € × 14.0x = 997 579 €
Range: 694 698€ - 1 492 435€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS

What is the revenue of SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS ?

The revenue of SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS in 2022 is 1.3 M€.

Is SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS profitable?

Yes, SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS generated a net profit of 71 k€ in 2024.

Where is the headquarters of SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS ?

The headquarters of SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS is located in SAINT OMER (62500), in the department Pas-de-Calais.

Where to find the tax return of SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS ?

The tax return of SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS operate?

SELARL DE PHARMACIENS D'OFFICINE PHARMACIE DE L'AUDOMAROIS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.